Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory Antibodies

Cancer Research - United States
doi 10.1158/0008-5472.can-12-0210
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy

Frontiers in Immunology
AllergyImmunology
2019English

Stromal PTEN Determines Mammary Epithelial Response to Radiotherapy

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Canine Mammary Tumors

Pathologia veterinaria
1970English

The Small Molecule TGF-β Signaling Inhibitor SM16 Synergizes With Agonistic OX40 Antibody to Suppress Established Mammary Tumors and Reduce Spontaneous Metastasis

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2011English

Local Control of Metastatic Bone Tumors by Intraoperative Radiotherapy.

Orthopedics & Traumatology
1995English

Correction: TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-Cell Persistence and Rejection of Established Tumors

Cancer Research
Cancer ResearchOncology
2017English

Enzymohistochemical Studies in Mammary Tumors

Proceedings of the Japanese Histochemical Association
1964English

Retinol-Binding Protein 4 Accelerates Metastatic Spread and Increases Impairment of Blood Flow in Mouse Mammary Gland Tumors

Cancers
Cancer ResearchOncology
2020English

RNA-modified T Cells Mediate Effective Delivery of Immunomodulatory Cytokines to Brain Tumors

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy